CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside
出版年份 2020 全文链接
标题
CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside
作者
关键词
-
出版物
BRITISH JOURNAL OF HAEMATOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-06-07
DOI
10.1111/bjh.16807
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pivotal Safety and Efficacy Results from Transcend NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel (liso-cel) in Relapsed/Refractory (R/R) Large B Cell Lymphomas
- (2020) Jeremy S. Abramson et al. BLOOD
- CRISPR-engineered T cells in patients with refractory cancer
- (2020) Edward A. Stadtmauer et al. SCIENCE
- Effective multi-lineage engraftment in a mouse model of Fanconi anemia using non-genotoxic antibody-based conditioning
- (2020) Meera A. Srikanthan et al. Molecular Therapy-Methods & Clinical Development
- A20 and RBX1 regulate brentuximab vedotin sensitivity in Hodgkin Lymphoma models
- (2020) Wei Wei et al. CLINICAL CANCER RESEARCH
- Genome editing of donor-derived T-cells to generate allogenic chimeric antigen receptor-modified T cells: Optimizing αβ T cell-depleted haploidentical hematopoietic stem cell transplantation
- (2020) Volker Wiebking et al. HAEMATOLOGICA
- Therapeutic base editing of human hematopoietic stem cells
- (2020) Jing Zeng et al. NATURE MEDICINE
- Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants
- (2020) Russell T. Walton et al. SCIENCE
- DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathway
- (2020) Caroline Dafflon et al. Oncotarget
- CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model
- (2020) Suet Ling Felce et al. Frontiers in Oncology
- Anti-human CD117 antibody-mediated bone marrow niche clearance in non-human primates and humanized NSG mice
- (2019) Hye-Sook Kwon et al. BLOOD
- Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10
- (2019) Morgan L. Maeder et al. NATURE MEDICINE
- TALEN-Mediated Gene Editing of HBG in Human Hematopoietic Stem Cells Leads to Therapeutic Fetal Hemoglobin Induction
- (2019) Christopher T. Lux et al. Molecular Therapy-Methods & Clinical Development
- Hematopoietic chimerism and donor-specific skin allograft tolerance after non-genotoxic CD117 antibody-drug-conjugate conditioning in MHC-mismatched allotransplantation
- (2019) Zhanzhuo Li et al. Nature Communications
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- Highly efficient therapeutic gene editing of human hematopoietic stem cells
- (2019) Yuxuan Wu et al. NATURE MEDICINE
- Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing
- (2019) Benjamin P. Kleinstiver et al. NATURE BIOTECHNOLOGY
- HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
- (2019) Ravindra K. Gupta et al. NATURE
- CRISPR to fix bad blood: a new tool in basic and clinical hematology
- (2019) Elisa González-Romero et al. HAEMATOLOGICA
- Editing the Sickle Cell Disease Mutation in Primary Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates
- (2019) Zulema Romero et al. MOLECULAR THERAPY
- Targeted homology-directed repair in blood stem and progenitor cells with CRISPR nanoformulations
- (2019) Reza Shahbazi et al. NATURE MATERIALS
- Molecular scissors cut in on stem cells
- (2019) Anna Azvolinsky NATURE MEDICINE
- Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1
- (2019) Ewelina Mamcarz et al. NEW ENGLAND JOURNAL OF MEDICINE
- A novel model of controlling PD-L1 expression in ALK+ anaplastic large cell lymphoma revealed by CRISPR screening
- (2019) Jing-Ping Zhang et al. BLOOD
- Therapeutically relevant engraftment of a CRISPR-Cas9–edited HSC-enriched population with HbF reactivation in nonhuman primates
- (2019) Olivier Humbert et al. Science Translational Medicine
- Gene correction for SCID-X1 in long-term hematopoietic stem cells
- (2019) Mara Pavel-Dinu et al. Nature Communications
- Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice
- (2019) Prasanta K. Dash et al. Nature Communications
- NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia
- (2019) Francisco José Román-Rodríguez et al. Cell Stem Cell
- Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia
- (2019) Paula Río et al. NATURE MEDICINE
- CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia
- (2019) Lei Xu et al. NEW ENGLAND JOURNAL OF MEDICINE
- In Vivo Outcome of Homology-Directed Repair at the HBB Gene in HSC Using Alternative Donor Template Delivery Methods
- (2019) Sowmya Pattabhi et al. Molecular Therapy-Nucleic Acids
- Search-and-replace genome editing without double-strand breaks or donor DNA
- (2019) Andrew V. Anzalone et al. NATURE
- Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma
- (2019) Michael A. Dengler et al. ONCOGENE
- Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
- (2019) Natalia Gomez-Ospina et al. Nature Communications
- Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors
- (2019) Beau R. Webber et al. Nature Communications
- Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease
- (2019) Weizhong Chen et al. PLOS BIOLOGY
- Endogenous CRISPR-Cas System-Based Genome Editing and Antimicrobials: Review and Prospects
- (2019) Yingjun Li et al. Frontiers in Microbiology
- Advances in genome editing through control of DNA repair pathways
- (2019) Charles D. Yeh et al. NATURE CELL BIOLOGY
- Gene therapy and gene editing strategies for hemoglobinopathies
- (2018) Maria Rosa Lidonnici et al. BLOOD CELLS MOLECULES AND DISEASES
- Counterpoint: The Potential Harms of Human Gene Editing Using CRISPR-Cas9
- (2018) Françoise Baylis CLINICAL CHEMISTRY
- Gene therapy for sickle cell disease: An update
- (2018) Selami Demirci et al. CYTOTHERAPY
- Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML
- (2018) S. Haubner et al. LEUKEMIA
- Myeloid Conditioning with c-kit-Targeted CAR-T Cells Enables Donor Stem Cell Engraftment
- (2018) Yasuyuki Arai et al. MOLECULAR THERAPY
- Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34 + Hematopoietic Stem and Progenitor Cells
- (2018) M. Kyle Cromer et al. MOLECULAR THERAPY
- p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
- (2018) Robert J. Ihry et al. NATURE MEDICINE
- CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response
- (2018) Emma Haapaniemi et al. NATURE MEDICINE
- CRISPR/Cas9 genome editing in human hematopoietic stem cells
- (2018) Rasmus O Bak et al. Nature Protocols
- Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
- (2018) Alexis A. Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6
- (2018) Jonathan S. Gootenberg et al. SCIENCE
- Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
- (2018) Jayesh A. Kulkarni et al. Nucleic Acid Therapeutics
- Differential impact of transplantation on peripheral and tissue-associated viral reservoirs: Implications for HIV gene therapy
- (2018) Christopher W. Peterson et al. PLoS Pathogens
- Efficient Enrichment of Gene-Modified Primary T Cells via CCR5-Targeted Integration of Mutant Dihydrofolate Reductase
- (2018) Biswajit Paul et al. Molecular Therapy-Methods & Clinical Development
- Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population
- (2018) Vijaya L. Simhadri et al. Molecular Therapy-Methods & Clinical Development
- HDAd5/35 ++ Adenovirus Vector Expressing Anti-CRISPR Peptides Decreases CRISPR/Cas9 Toxicity in Human Hematopoietic Stem Cells
- (2018) Chang Li et al. Molecular Therapy-Methods & Clinical Development
- In vivo CRISPR editing with no detectable genome-wide off-target mutations
- (2018) Pinar Akcakaya et al. NATURE
- A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
- (2018) Christopher A. Vakulskas et al. NATURE MEDICINE
- The STING-STAT6 pathway drives Cas9-induced host response in human monocytes
- (2018) Rui Kang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia
- (2018) Hongjie Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Engineering resistance to CD33-targeted immunotherapy in normal hematopoiesis by CRISPR/Cas9-deletion of CD33 exon 2
- (2018) Olivier Humbert et al. LEUKEMIA
- Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements
- (2018) Annalisa Lattanzi et al. MOLECULAR THERAPY
- Genome-edited baby claim provokes international outcry
- (2018) David Cyranoski et al. NATURE
- Sangamo's landmark genome editing trial gets mixed reception
- (2018) Cormac Sheridan NATURE BIOTECHNOLOGY
- Correction: Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
- (2018) Rasmus O Bak et al. eLife
- Allogeneic CAR-T Cells: More than Ease of Access?
- (2018) Charlotte Graham et al. Cells
- Clinical efficacy of gene-modified stem cells in adenosine deaminase–deficient immunodeficiency
- (2017) Kit L. Shaw et al. JOURNAL OF CLINICAL INVESTIGATION
- Rhesus iPSC Safe Harbor Gene-Editing Platform for Stable Expression of Transgenes in Differentiated Cells of All Germ Layers
- (2017) So Gun Hong et al. MOLECULAR THERAPY
- CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo
- (2017) Lei Xu et al. MOLECULAR THERAPY
- Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
- (2017) Justin Eyquem et al. NATURE
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
- (2017) Nicole M. Gaudelli et al. NATURE
- HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
- (2017) Germán G Gornalusse et al. NATURE BIOTECHNOLOGY
- Refining strategies to translate genome editing to the clinic
- (2017) Tatjana I Cornu et al. NATURE MEDICINE
- Unexpected mutations after CRISPR–Cas9 editing in vivo
- (2017) Kellie A Schaefer et al. NATURE METHODS
- Marker-free coselection for CRISPR-driven genome editing in human cells
- (2017) Daniel Agudelo et al. NATURE METHODS
- Gene Therapy in a Patient with Sickle Cell Disease
- (2017) Jean-Antoine Ribeil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nucleic acid detection with CRISPR-Cas13a/C2c2
- (2017) Jonathan S. Gootenberg et al. SCIENCE
- A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates
- (2017) Stefan Radtke et al. Science Translational Medicine
- Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
- (2017) Waseem Qasim et al. Science Translational Medicine
- Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34 + Hematopoietic Stem and Progenitor Cells
- (2017) Kai-Hsin Chang et al. Molecular Therapy-Methods & Clinical Development
- Disabling Cas9 by an anti-CRISPR DNA mimic
- (2017) Jiyung Shin et al. Science Advances
- Genome Editing: A New Approach to Human Therapeutics
- (2016) Matthew Porteus Annual Review of Pharmacology and Toxicology
- Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
- (2016) Jiangtao Ren et al. CLINICAL CANCER RESEARCH
- CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
- (2016) Daniel P. Dever et al. NATURE
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin
- (2016) Rahul Palchaudhuri et al. NATURE BIOTECHNOLOGY
- A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition
- (2016) Elizabeth A Traxler et al. NATURE MEDICINE
- Defining and improving the genome-wide specificities of CRISPR–Cas9 nucleases
- (2016) Shengdar Q. Tsai et al. NATURE REVIEWS GENETICS
- Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia
- (2016) Lin Ye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
- (2016) M. A. DeWitt et al. Science Translational Medicine
- Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell Immunotherapies
- (2015) Laurent Poirot et al. CANCER RESEARCH
- Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
- (2015) Ayal Hendel et al. NATURE BIOTECHNOLOGY
- Nonirradiated NOD,B6.SCID Il2rγ−/− KitW41/W41 (NBSGW) Mice Support Multilineage Engraftment of Human Hematopoietic Cells
- (2015) Brian E. McIntosh et al. Stem Cell Reports
- Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
- (2014) Hien K. Duong et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
- (2014) Luke A. Gilbert et al. CELL
- Efficient Ablation of Genes in Human Hematopoietic Stem and Effector Cells using CRISPR/Cas9
- (2014) Pankaj K. Mandal et al. Cell Stem Cell
- Targeted genome editing in human repopulating haematopoietic stem cells
- (2014) Pietro Genovese et al. NATURE
- Microhomology-based choice of Cas9 nuclease target sites
- (2014) Sangsu Bae et al. NATURE METHODS
- Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
- (2014) Pablo Tebas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene-modified hematopoietic stem cells for cancer immunotherapy
- (2014) Sarah Larson et al. Human Vaccines & Immunotherapeutics
- CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering
- (2013) Prashant Mali et al. NATURE BIOTECHNOLOGY
- Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
- (2013) Seung Woo Cho et al. NATURE BIOTECHNOLOGY
- megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering
- (2013) Sandrine Boissel et al. NUCLEIC ACIDS RESEARCH
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Chemoselection of Allogeneic HSC After Murine Neonatal Transplantation Without Myeloablation or Post-transplant Immunosuppression
- (2012) Rustom Falahati et al. MOLECULAR THERAPY
- Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
- (2012) G. Gasiunas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Targeting DNA Double-Strand Breaks with TAL Effector Nucleases
- (2010) M. Christian et al. GENETICS
- Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates
- (2010) Brian C. Beard et al. JOURNAL OF CLINICAL INVESTIGATION
- Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells
- (2010) Eirini P Papapetrou et al. NATURE BIOTECHNOLOGY
- TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain
- (2010) Ting Li et al. NUCLEIC ACIDS RESEARCH
- Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?
- (2009) Courtney D. Fitzhugh et al. CYTOTHERAPY
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
- (2008) Steven J. Howe et al. JOURNAL OF CLINICAL INVESTIGATION
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
- (2008) Salima Hacein-Bey-Abina et al. JOURNAL OF CLINICAL INVESTIGATION
- Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
- (2008) Elena E Perez et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started